Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Endoscopic follow-up of low-grade precancerous bronchial lesions in high-risk patients: long-term results of the SELEPREBB randomised multicentre trial.
Guisier F, Deslee G, Birembaut P, Escarguel B, Chapel F, Bota S, Métayer J, Lachkar S, Capron F, Homasson JP, Taulelle M, Quintana M, Raspaud C, Messelet D, Benzaquen J, Hofman P, Baddredine J, Paris C, Cales V, Laurent P, Vignaud JM, Ménard O, Copin MC, Ramon P, Bouchindhomme B, Tavernier JY, Quintin I, Quiot JJ, Galateau-Sallé F, Zalcman G, Piton N, Thiberville L. Guisier F, et al. Among authors: taulelle m. Eur Respir J. 2022 Sep 15;60(3):2101946. doi: 10.1183/13993003.01946-2021. Print 2022 Sep. Eur Respir J. 2022. PMID: 35236723 Free article. Clinical Trial.
After baseline lung computed tomography (CT) and autofluorescence bronchoscopy (AFB) to exclude lung cancer and bronchial severe squamous dysplasia or carcinoma in situ (CIS), patients were assigned to standard surveillance (arm A) with CT and AFB at 36 months or to intensive sur …
After baseline lung computed tomography (CT) and autofluorescence bronchoscopy (AFB) to exclude lung cancer and bronchial severe squamous dy …
[Concomitant radiochemotherapy for locally advanced bronchial cancers: current results and prospects].
Reboul F, Vincent P, Brewer Y, Taulelle M. Reboul F, et al. Among authors: taulelle m. Cancer Radiother. 1997;1(2):113-20. doi: 10.1016/s1278-3218(97)83527-5. Cancer Radiother. 1997. PMID: 9273180 French.
In non-small cell lung cancer, radiation therapy alone results in disappointing long-term survival. Three recent randomized trials, however, have shown a limited but significant improvement of survival with induction chemotherapy, though local control remained poor in thes …
In non-small cell lung cancer, radiation therapy alone results in disappointing long-term survival. Three recent randomized trials, h …
Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M. Reboul F, et al. Among authors: taulelle m. Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):343-50. doi: 10.1016/0360-3016(96)00087-9. Int J Radiat Oncol Biol Phys. 1996. PMID: 8635942 Clinical Trial.
In recent years, several Phase III trials have demonstrated encouraging results with induction chemotherapy, but with poor long-term local control. Concurrent cisplatin alone during the radiation therapy course has resulted in improved local control, but without efficacy o …
In recent years, several Phase III trials have demonstrated encouraging results with induction chemotherapy, but with poor long-term
[Localized small-cell lung cancers: prospects of concomitant radiochemotherapy].
Reboul F, Vincent P, Brewer Y, Chauvet B, Taulelle M. Reboul F, et al. Among authors: taulelle m. Bull Cancer. 1995 Dec;82(12):996-1004. Bull Cancer. 1995. PMID: 8745665 Review. French.
Radiosensitizing properties of cisplatin and etoposide have been demonstrated, and concurrent delivery of radiotherapy results in a high complete response rate on the primary tumor, and improved long-term local control, which is a prerequisite for cure. In addition, a redu …
Radiosensitizing properties of cisplatin and etoposide have been demonstrated, and concurrent delivery of radiotherapy results in a high com …
[Radiotherapy and concomitant cisplatin in stage III non-small cell bronchial cancer: results of a pilot study].
Reboul F, Vincent P, Chauvet B, Brewer Y, Serin D, Félix-Faure C, Taulelle M. Reboul F, et al. Among authors: taulelle m. Bull Cancer. 1995 Mar;82(3):196-201. Bull Cancer. 1995. PMID: 7655147 Clinical Trial. French.
There were no local recurrence or distant relapses after 3 years, which will hopefully result in long-term survival in one quarter of these patients. These results compare favorably with other studies combining radiation therapy and concomitant cisplatin with different dos …
There were no local recurrence or distant relapses after 3 years, which will hopefully result in long-term survival in one quarter of …
[Treatment of obstructive bronchial cancers with high dose, endobronchial curietherapy. Technical aspects and clinical results].
Taulelle M, De Faucal H, Bénézet O, Yacono M, Chauvet B, Vincent P, Bucciarelli B, Brewer Y, Félix-Faure C, Reboul F. Taulelle M, et al. Rev Mal Respir. 1993;10(4):347-51. Rev Mal Respir. 1993. PMID: 7694332 French.
Ongoing radiobiological research should determine an optimal therapeutic approach in term of efficacy and long term toxicity before using endobronchial brachytherapy as a part of the initial management of unresectable lung cancers....
Ongoing radiobiological research should determine an optimal therapeutic approach in term of efficacy and long term toxicity b …